D.A. Davidson & Co. Teva Pharmaceutical Industries LTD Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, D.A. Davidson & Co. holds 86,511 shares of TEVA stock, worth $1.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

86,511

Previous 81,254 6.47%

Holding current value

$1.94 Million

Previous $1.32 Million 18.03%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.81 - $18.96 $83,113 - $99,672	5,257 Added 6.47%	86,511 $1.56 Million
Q2 2024 Jul 31, 2024	BUY	$12.78 - $17.4 $135,864 - $184,979	10,631 Added 15.05%	81,254 $1.32 Million
Q1 2024 May 13, 2024	BUY	$10.67 - $14.43 $523,406 - $707,849	49,054 Added 227.43%	70,623 $996,000
Q4 2023 Feb 09, 2024	SELL	$8.12 - $10.63 $3,207 - $4,198	-395 Reduced 1.8%	21,569 $225,000
Q1 2023 Apr 25, 2023	SELL	$8.36 - $11.37 $4,180 - $5,685	-500 Reduced 2.23%	21,964 $194,000
Q4 2022 Feb 03, 2023	SELL	$7.95 - $9.48 $3,180 - $3,792	-400 Reduced 1.75%	22,464 $204,000
Q3 2022 Nov 07, 2022	BUY	$6.86 - $11.95 $17,554 - $30,580	2,559 Added 12.6%	22,864 $185,000
Q2 2022 Jul 28, 2022	SELL	$7.38 - $10.4 $11,033 - $15,548	-1,495 Reduced 6.86%	20,305 $153,000
Q1 2022 May 12, 2022	BUY	$7.33 - $9.39 $1,370 - $1,755	187 Added 0.87%	21,800 $205,000
Q4 2021 Jan 31, 2022	SELL	$7.9 - $10.19 $16,661 - $21,490	-2,109 Reduced 8.89%	21,613 $173,000
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $13,408 - $16,288	-1,600 Reduced 6.32%	23,722 $231,000
Q2 2021 Aug 10, 2021	SELL	$9.9 - $11.56 $13,820 - $16,137	-1,396 Reduced 5.22%	25,322 $251,000
Q1 2021 May 07, 2021	BUY	$10.34 - $12.81 $26,997 - $33,446	2,611 Added 10.83%	26,718 $308,000
Q4 2020 Feb 10, 2021	SELL	$8.61 - $11.04 $15,541 - $19,927	-1,805 Reduced 6.97%	24,107 $233,000
Q3 2020 Nov 02, 2020	SELL	$8.57 - $12.69 $9,315 - $13,794	-1,087 Reduced 4.03%	25,912 $233,000
Q2 2020 Aug 10, 2020	SELL	$8.12 - $13.12 $37,847 - $61,152	-4,661 Reduced 14.72%	26,999 $333,000
Q1 2020 May 05, 2020	SELL	$6.69 - $13.45 $2,575 - $5,178	-385 Reduced 1.2%	31,660 $284,000
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $8,169 - $13,410	1,251 Added 4.06%	32,045 $314,000
Q3 2019 Nov 05, 2019	SELL	$6.16 - $9.6 $14,476 - $22,560	-2,350 Reduced 7.09%	30,794 $212,000
Q2 2019 Aug 13, 2019	SELL	$8.12 - $15.72 $118,738 - $229,873	-14,623 Reduced 30.61%	33,144 $306,000
Q1 2019 May 13, 2019	SELL	$15.58 - $20.01 $46,708 - $59,989	-2,998 Reduced 5.91%	47,767 $747,000
Q4 2018 Jan 29, 2019	SELL	$14.59 - $23.84 $3,997 - $6,532	-274 Reduced 0.54%	50,765 $783,000
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $32,516 - $39,603	1,544 Added 3.12%	51,039 $1.1 Million
Q2 2018 Aug 02, 2018	BUY	$16.77 - $24.71 $12,091 - $17,815	721 Added 1.48%	49,495 $1.2 Million
Q1 2018 May 04, 2018	SELL	$16.68 - $22.07 $84,484 - $111,784	-5,065 Reduced 9.41%	48,774 $834,000
Q4 2017 Feb 08, 2018	SELL	$11.23 - $19.1 $121,553 - $206,738	-10,824 Reduced 16.74%	53,839 $1.02 Million
Q3 2017 Nov 08, 2017	SELL	$15.41 - $32.17 $3.11 Million - $6.49 Million	-201,758 Reduced 75.73%	64,663 $1.14 Million
Q2 2017 Aug 11, 2017	BUY	N/A	266,421	266,421 $0

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account